Rita Mozzi

Rita Mozzi

Auto-generated profile, based on publicly available information

Rita Mozzi

From the Department of Experimental and Clinical Medicine, Section of Occupational Medicine, University of Perugia, Piazzale G. Menghini 3 (Drs Gambelunghe, Murgia, and Muzi), Perugia, Italy

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
AGAngela Gambelunghe
Angela Gambelunghe
Sandra BurattaSandra Buratta
Sandra Buratta
GFGiuseppina Ferrara
Giuseppina Ferrara
RMRita Mozzi
Rita Mozzi
CMCRISTINA MARCHETTI
CRISTINA MARCHETTI
GMGiacomo Muzi
Giacomo Muzi
Hexavalent chromium (Cr(VI)) compounds are widely found in different working environments. These compounds can cause apoptosis in human cells, but the mechanisms underlying chromium-induced apoptosis are not clear. A marker of apoptosis is the exposure of phosphatidylserine on cell membrane and the modification of phosphatidylserine metabolism. The aim of this study was to verify whether chromium could cause phosphatidylserine exposure and modification of its metabolism in human lymphoblastic leukemia cell line (MOLT-4). Phosphatidylserine exposure was evaluated by annexin V binding whereas phosphatidylserine metabolism was studied measuring the incorporation of [3H]serine. Cell treatment with Cr(VI) increases phosphatidylserine exposure and cell apoptosis, but decreases the incorporation of [3H]serine into phosphatidylserine in a dose- and time-dependent manner. The Cr(VI)-induced apoptosis also through modification of phosphatidylserine exposure and metabolism.